283 related articles for article (PubMed ID: 31009315)
1. Evaluating the Impact of Variable Phosphorothioate Content in Tricyclo-DNA Antisense Oligonucleotides in a Duchenne Muscular Dystrophy Mouse Model.
Echevarría L; Aupy P; Relizani K; Bestetti T; Griffith G; Blandel F; Komisarski M; Haeberli A; Svinartchouk F; Garcia L; Goyenvalle A
Nucleic Acid Ther; 2019 Jun; 29(3):148-160. PubMed ID: 31009315
[TBL] [Abstract][Full Text] [Related]
2. Identifying and Avoiding tcDNA-ASO Sequence-Specific Toxicity for the Development of DMD Exon 51 Skipping Therapy.
Aupy P; Echevarría L; Relizani K; Zarrouki F; Haeberli A; Komisarski M; Tensorer T; Jouvion G; Svinartchouk F; Garcia L; Goyenvalle A
Mol Ther Nucleic Acids; 2020 Mar; 19():371-383. PubMed ID: 31881528
[TBL] [Abstract][Full Text] [Related]
3. The Use of Antisense Oligonucleotides for the Treatment of Duchenne Muscular Dystrophy.
Relizani K; Goyenvalle A
Methods Mol Biol; 2018; 1687():171-183. PubMed ID: 29067663
[TBL] [Abstract][Full Text] [Related]
4. Palmitic acid conjugation enhances potency of tricyclo-DNA splice switching oligonucleotides.
Relizani K; Echevarría L; Zarrouki F; Gastaldi C; Dambrune C; Aupy P; Haeberli A; Komisarski M; Tensorer T; Larcher T; Svinartchouk F; Vaillend C; Garcia L; Goyenvalle A
Nucleic Acids Res; 2022 Jan; 50(1):17-34. PubMed ID: 34893881
[TBL] [Abstract][Full Text] [Related]
5. Impact of the Inhibition of Organic Anion Transporter on Tricyclo-DNA-Mediated Exon Skipping in the
Bizot F; Tensorer T; Garcia L; Goyenvalle A
Nucleic Acid Ther; 2023 Dec; 33(6):374-380. PubMed ID: 37967388
[TBL] [Abstract][Full Text] [Related]
6. Peptide conjugation of 2'-O-methyl phosphorothioate antisense oligonucleotides enhances cardiac uptake and exon skipping in mdx mice.
Jirka SM; Heemskerk H; Tanganyika-de Winter CL; Muilwijk D; Pang KH; de Visser PC; Janson A; Karnaoukh TG; Vermue R; 't Hoen PA; van Deutekom JC; Aguilera B; Aartsma-Rus A
Nucleic Acid Ther; 2014 Feb; 24(1):25-36. PubMed ID: 24320790
[TBL] [Abstract][Full Text] [Related]
7. Dose-dependent pharmacokinetic profiles of 2'-O-methyl phosphorothioate antisense oligonucleotidesin mdx mice.
Verhaart IE; Tanganyika-de Winter CL; Karnaoukh TG; Kolfschoten IG; de Kimpe SJ; van Deutekom JC; Aartsma-Rus A
Nucleic Acid Ther; 2013 Jun; 23(3):228-37. PubMed ID: 23634945
[TBL] [Abstract][Full Text] [Related]
8. In vivo comparison of 2'-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping.
Heemskerk HA; de Winter CL; de Kimpe SJ; van Kuik-Romeijn P; Heuvelmans N; Platenburg GJ; van Ommen GJ; van Deutekom JC; Aartsma-Rus A
J Gene Med; 2009 Mar; 11(3):257-66. PubMed ID: 19140108
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety Profile of Tricyclo-DNA Antisense Oligonucleotides in Duchenne Muscular Dystrophy Mouse Model.
Relizani K; Griffith G; Echevarría L; Zarrouki F; Facchinetti P; Vaillend C; Leumann C; Garcia L; Goyenvalle A
Mol Ther Nucleic Acids; 2017 Sep; 8():144-157. PubMed ID: 28918017
[TBL] [Abstract][Full Text] [Related]
10. The Pharmacokinetics of 2'-
Bosgra S; Sipkens J; de Kimpe S; den Besten C; Datson N; van Deutekom J
Nucleic Acid Ther; 2019 Dec; 29(6):305-322. PubMed ID: 31429628
[TBL] [Abstract][Full Text] [Related]
11. Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers.
Goyenvalle A; Griffith G; Babbs A; El Andaloussi S; Ezzat K; Avril A; Dugovic B; Chaussenot R; Ferry A; Voit T; Amthor H; Bühr C; Schürch S; Wood MJ; Davies KE; Vaillend C; Leumann C; Garcia L
Nat Med; 2015 Mar; 21(3):270-5. PubMed ID: 25642938
[TBL] [Abstract][Full Text] [Related]
12. Nonclinical Exon Skipping Studies with 2'-O-Methyl Phosphorothioate Antisense Oligonucleotides in mdx and mdx-utrn-/- Mice Inspired by Clinical Trial Results.
van Putten M; Tanganyika-de Winter C; Bosgra S; Aartsma-Rus A
Nucleic Acid Ther; 2019 Apr; 29(2):92-103. PubMed ID: 30672725
[TBL] [Abstract][Full Text] [Related]
13. Partial Restoration of Brain Dystrophin and Behavioral Deficits by Exon Skipping in the Muscular Dystrophy X-Linked (mdx) Mouse.
Zarrouki F; Relizani K; Bizot F; Tensorer T; Garcia L; Vaillend C; Goyenvalle A
Ann Neurol; 2022 Aug; 92(2):213-229. PubMed ID: 35587226
[TBL] [Abstract][Full Text] [Related]
14. Investigating the Impact of Delivery Routes for Exon Skipping Therapies in the CNS of DMD Mouse Models.
Saoudi A; Fergus C; Gileadi T; Montanaro F; Morgan JE; Kelly VP; Tensorer T; Garcia L; Vaillend C; Muntoni F; Goyenvalle A
Cells; 2023 Mar; 12(6):. PubMed ID: 36980249
[TBL] [Abstract][Full Text] [Related]
15. Exon Skipping Therapy Using Phosphorodiamidate Morpholino Oligomers in the mdx52 Mouse Model of Duchenne Muscular Dystrophy.
Miyatake S; Mizobe Y; Takizawa H; Hara Y; Yokota T; Takeda S; Aoki Y
Methods Mol Biol; 2018; 1687():123-141. PubMed ID: 29067660
[TBL] [Abstract][Full Text] [Related]
16. Effective exon skipping and dystrophin restoration by 2'-o-methoxyethyl antisense oligonucleotide in dystrophin-deficient mice.
Yang L; Niu H; Gao X; Wang Q; Han G; Cao L; Cai C; Weiler J; Yin H
PLoS One; 2013; 8(4):e61584. PubMed ID: 23658612
[TBL] [Abstract][Full Text] [Related]
17. Development of antisense-mediated exon skipping as a treatment for duchenne muscular dystrophy.
Heemskerk H; de Winter CL; van Ommen GJ; van Deutekom JC; Aartsma-Rus A
Ann N Y Acad Sci; 2009 Sep; 1175():71-9. PubMed ID: 19796079
[TBL] [Abstract][Full Text] [Related]
18. Use of Tricyclo-DNA Antisense Oligonucleotides for Exon Skipping.
Relizani K; Goyenvalle A
Methods Mol Biol; 2018; 1828():381-394. PubMed ID: 30171555
[TBL] [Abstract][Full Text] [Related]
19. Self-Assembly into Nanoparticles Is Essential for Receptor Mediated Uptake of Therapeutic Antisense Oligonucleotides.
Ezzat K; Aoki Y; Koo T; McClorey G; Benner L; Coenen-Stass A; O'Donovan L; Lehto T; Garcia-Guerra A; Nordin J; Saleh AF; Behlke M; Morris J; Goyenvalle A; Dugovic B; Leumann C; Gordon S; Gait MJ; El-Andaloussi S; Wood MJ
Nano Lett; 2015 Jul; 15(7):4364-73. PubMed ID: 26042553
[TBL] [Abstract][Full Text] [Related]
20. In Vivo Evaluation of Single-Exon and Multiexon Skipping in mdx52 Mice.
Mizobe Y; Miyatake S; Takizawa H; Hara Y; Yokota T; Nakamura A; Takeda S; Aoki Y
Methods Mol Biol; 2018; 1828():275-292. PubMed ID: 30171548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
